• Ireland commits EUR 18 million in new funding to Gavi, the Vaccine Alliance for the 2021-25 period
  • The support will help immunise 300 million children over the next five years and strengthen health systems, saving up to 8 million lives
  • Dr Seth Berkley: “We are grateful to Ireland as this is absolutely vital funding”

Geneva, 6 May 2020Ireland has announced EUR 18 million in new direct funding to Gavi, the Vaccine Alliance, to support the vaccination of hundreds of millions of children against diseases like measles, polio and pneumonia over the next five years and support Gavi’s response to the COVID-19 pandemic. The new pledge, made at the European Union’s Coronavirus Global Response pledging conference, is a 20% increase from Ireland’s previous EUR 15 million five-year pledge to the 2016-2020 period.

Taoiseach Leo Varadkar emphasises that “working together, we can develop an effective vaccine, effective treatments, testing systems that work, diagnostics and therapeutics. Ireland wants to play its part, therefore I am announcing a new pledge of EUR 18 million to Gavi – to ensure that the poorest countries in the world will have access to the COVID-19 vaccine, if and when it is developed. It’s really important that nobody in the world is left out when that happens.”

Ireland has been a Gavi donor since 2002 and has a strong commitment to the organisation and its mission. Gavi’s focus on the world’s poorest and most fragile countries is closely aligned with Ireland’s vision of a more equal and sustainable world that leaves no one behind.

“We are grateful to Ireland as this is absolutely vital funding, which will help us both vaccinate millions of the most vulnerable children as well as help us preparing for a potential roll-out of a COVID-19 vaccine to the most vulnerable,” said Dr Seth Berkley, CEO of Gavi, the Vaccine Alliance. “The development of a COVID-19 vaccine is our best chance of beating this disease, which is why yesterday’s pledging conference was so important. We should also ensure that vaccination continues in all Gavi-supported countries as we cannot afford other deadly epidemics. As we have seen, diseases do not respect borders and immunisation is our best shield against future pandemics.”

Gavi needs at least US$ 7.4 billion for the 2021-25 period to protect 300 million children in 68 lower-income countries against deadly diseases. This funding will also ensure that the immunisation systems needed to deliver a COVID-19 vaccine are sustained through the pandemic. Gavi’s replenishment will conclude at the Global Vaccine Summit, hosted by the UK government on 4 June.

Over 20 years, Gavi has helped to immunise more than 760 million children, saving more than 13 million lives. Over that time, the Alliance has also worked to strengthen health systems in the world’s poorest countries and establish vaccine stockpiles against serious global health security threats, including Ebola.


COVID-19 related

13 September 2022

How long after I get COVID-19 will I test negative?

Testing positive for COVID-19 – even without symptoms – can be disruptive to daily life, but how long should we expect to test positive for?

First published on 29 October 2021, updated on 13 September 2022

5 September 2022

Call for Applications: COVAX seeks experts for independent group on evidence-based vaccine decision-making

The COVAX Facility is seeking expressions of interest from the subject matter experts to join the COVAX Independent Product Group. The Independent Product Group (“IPG”) is established to provide scientific advice on COVID-19 vaccines and make…

24 February 2022

Q&A: Science ‘needs to listen to African voices’

Public speaking a lifelong skill for scientists. Drive behind research should come from grassroots. Science and art merge together in field of communication.

8 February 2022

How did Kenya surpass its 2021 COVID-19 vaccination target?

Kenya was aiming to reach 10 million people with COVID-19 vaccines by the end of December 2021. Thanks to a clear strategy, COVAX support and the hard work of thousands of health workers, they reached their target.

4 February 2022

Could mRNA vaccines protect against HIV?

Moderna has begun a trial with an experimental HIV vaccine based on the same technology underpinning its COVID-19 vaccine.

3 February 2022

What’s the best way to tackle COVID and climate change? Anthropology, says the woman who predicted the global financial crisis

Financial Times journalist and author Gillian Tett discusses her new book, Anthro-Vision: How Anthropology Can Explain Business and Life.

3 February 2022

The Equity Agenda in Fourth Industrial Revolution Healthcare Technology

The COVID-19 pandemic has demonstrated the power of innovative Fourth Industrial Revolution (4IR) technologies in healthcare systems. Unless these technologies are designed with equity at their core, we risk leaving some people even further…

3 February 2022

When it rains: how the global climate crisis is already threatening public health on the shores of Lake Victoria

Faced with the many disease threats posed by repeated, calamitous floods, Nyando in western Kenya needs its health services more than ever. But longer-term resiliency will require more than just a shot in the arm.

2 February 2022

Myocarditis: COVID-19 is a much bigger risk to the heart than vaccination

Myocarditis following COVID-19 vaccination is rare, and the risk is much smaller than the risks of cardiac injury linked to COVID-19 itself.

Subscribe to our newsletter